BMP9 treatment of rat pups with experimental BPD attenuated neonatal chronic lung disease by improving aberrant alveolar development, demonstrated by reduced alveolar enlargement and septal thickness, and reducing pulmonary inflammation and extravascular collagen deposition. Here, GDF2 is linked to bronchopulmonary dysplasia.